NYSE ARCA | ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index.
The index is an equal-dollar weighted index designed to measure the performance of a cross section of small, mid and large capitalization companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| RARE | Ultragenyx | Healthcare | Biotechnology | 4.00% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.82% |
| CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 3.74% |
| QGEN | Qiagen NV | Healthcare | Diagnostics & Research | 3.65% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 3.58% |
| IQV | IQVIA Holdings Inc | Healthcare | Diagnostics & Research | 3.55% |
| RGEN | Repligen Corporation | Healthcare | Medical Instruments & Supplies | 3.54% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 3.48% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 3.45% |
| MTD | Mettler-Toledo International Inc | Healthcare | Diagnostics & Research | 3.45% |
| WAT | Waters Corporation | Healthcare | Diagnostics & Research | 3.43% |
| BGNE | BeiGene Ltd | Healthcare | Biotechnology | 3.41% |
| CRL | Charles River Laboratories | Healthcare | Diagnostics & Research | 3.41% |
| ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 3.40% |
| CPRX | Catalyst Pharmaceuticals Inc | Healthcare | Biotechnology | 3.40% |
| GMAB | Genmab AS | Healthcare | Biotechnology | 3.40% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 3.38% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 3.37% |
| UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 3.37% |
| HALO | Halozyme Therapeutics Inc | Healthcare | Biotechnology | 3.37% |